4//SEC Filing
Bopitiya Ranmali 4
Accession 0001562180-24-006661
CIK 0001568651other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:42 PM ET
Size
26.9 KB
Accession
0001562180-24-006661
Insider Transaction Report
Form 4
Bopitiya Ranmali
EVP & Chief Legal Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2024-09-01+108,932→ 288,060 total - Sale
Class A Common Stock
2024-09-04$17.46/sh−18,158$317,039→ 233,727 total - Sale
Class A Common Stock
2024-09-04$17.85/sh−14,820$264,537→ 218,907 total - Exercise/Conversion
Restricted Stock Units
2024-09-01−20,425→ 122,549 total→ Class A Common Stock (20,425 underlying) - Exercise/Conversion
Restricted Stock Units
2024-09-01−4,867→ 48,670 total→ Class A Common Stock (4,867 underlying) - Exercise/Conversion
Class A Common Stock
2024-09-01+20,425→ 157,813 total - Exercise/Conversion
Class A Common Stock
2024-09-01+16,448→ 174,261 total - Exercise/Conversion
Restricted Stock Units
2024-09-01−16,448→ 164,474 total→ Class A Common Stock (16,448 underlying) - Exercise/Conversion
Class A Common Stock
2024-09-01+4,867→ 179,128 total - Sale
Class A Common Stock
2024-09-03$17.99/sh−36,175$650,788→ 251,885 total
Footnotes (9)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The Issuer previously granted the Reporting Person an award of 108,932 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
- [F3]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F7]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.
- [F8]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
- [F9]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0001908069
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:42 PM ET
- Size
- 26.9 KB